Muhammad Khatib
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muhammad Khatib has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Ali Sleiman
Department of Orthopedic Surgery, Carmel Hospital, Haifa, Israel
1 shared publicationAlon Senderovich
Rabin Medical Center, Hasharon Hospital, Petah Tikva, Israel
1 shared publication- Amir Abu Alhija
Department of Orthopedic Surgery, Carmel Hospital, Haifa, Israel
1 shared publication - Assil Mahamid
Department of Orthopedic Surgery, Hasharon Hospital, Rabin Medical Center
1 shared publication - Dror Robinson
Department of Orthopedic Surgery, Hasharon Hospital, Rabin Medical Center
1 shared publication - Eitan Lavon
Management Department, Hasharon Hospital, Rabin Medical Center, Clalit Health Services, Petah Tikva 4937211, Israel
1 shared publication
Latest Publications
- Open Access
- 25 September 2026
- Published by National University of Health Sciences in Journal of Manipulative and Physiological Therapeutics
- Vol. 49 (1)
Enhanced training protocol improves concurrent validity of CLA Insight wireless inclinometry for lumbar range of motion assessment: A 317-participant validation study
Objective: The purpose of this study was to evaluate the concurrent validity and test–retest reliability of CLA Insight wireless inclinometry for lumbar range of motion (ROM) assessment compared with dual inclinometry and to assess whether enhanced training protocols improve measurement accuracy. Methods: This prospective validation study enrolled 317 adults with chronic low back pain (86 initial cohort, 231 subsequent cohort following enhanced training). Participants underwent same-day lumbar ROM assessment using both CLA wireless inclinometry (2 trials) and dual inclinometry in 4 directions (flexion, extension, lateral bending). Concurrent validity was assessed using intraclass correlation coefficients (ICC[3,1]) and Bland–Altman analysis. Test–retest reliability compared trial 1 vs trial 2 measurements. Results: In the combined data set, CLA demonstrated excellent concurrent validity (ICC = 0.929; 95% confidence interval [CI], 0.900–0.950; r = 0.886; P < .001) with minimal bias (−1.59°) and acceptable 95% limits of agreement (−10.27° to 7.08°). Enhanced training improved validity from good (ICC = 0.709) in the initial cohort to excellent (ICC = 0.992) in the subsequent cohort, representing a clinically meaningful enhancement in measurement agreement. Test–retest reliability was excellent (ICC = 0.974; MDC 95 = 3.87°). Manual clinical estimates showed poor agreement with objective measurements, overestimating ROM by 17°–19°. Over 12-month follow-up, flexion ROM improved by +11.24° ( P < .001), and the composite CORESCORE neurological index improved significantly from 64.9 to 73.3 (paired- t P < .001). Conclusion: CLA Insight wireless inclinometry demonstrates excellent concurrent validity and test–retest reliability for lumbar ROM assessment when combined with standardized training protocols. Enhanced training significantly improves measurement accuracy, providing an implementation framework for clinical adoption.
- 25 September 2026
- Published by National University of Health Sciences in Journal of Manipulative and Physiological Therapeutics
- Vol. 49 (1)
Open AccessEnhanced training protocol improves concurrent validity of CLA Insight wireless inclinometry for lumbar range of motion assessment: A 317-participant validation study
Objective: The purpose of this study was to evaluate the concurrent validity and test–retest reliability of CLA Insight wireless inclinometry for lumbar range of motion (ROM) assessment compared with dual inclinometry and to assess whether enhanced training protocols improve measurement accuracy. Methods: This prospective validation study enrolled 317 adults with chronic low back pain (86 initial cohort, 231 subsequent cohort following enhanced training). Participants underwent same-day lumbar ROM assessment using both CLA wireless inclinometry (2 trials) and dual inclinometry in 4 directions (flexion, extension, lateral bending). Concurrent validity was assessed using intraclass correlation coefficients (ICC[3,1]) and Bland–Altman analysis. Test–retest reliability compared trial 1 vs trial 2 measurements. Results: In the combined data set, CLA demonstrated excellent concurrent validity (ICC = 0.929; 95% confidence interval [CI], 0.900–0.950; r = 0.886; P < .001) with minimal bias (−1.59°) and acceptable 95% limits of agreement (−10.27° to 7.08°). Enhanced training improved validity from good (ICC = 0.709) in the initial cohort to excellent (ICC = 0.992) in the subsequent cohort, representing a clinically meaningful enhancement in measurement agreement. Test–retest reliability was excellent (ICC = 0.974; MDC 95 = 3.87°). Manual clinical estimates showed poor agreement with objective measurements, overestimating ROM by 17°–19°. Over 12-month follow-up, flexion ROM improved by +11.24° ( P < .001), and the composite CORESCORE neurological index improved significantly from 64.9 to 73.3 (paired- t P < .001). Conclusion: CLA Insight wireless inclinometry demonstrates excellent concurrent validity and test–retest reliability for lumbar ROM assessment when combined with standardized training protocols. Enhanced training significantly improves measurement accuracy, providing an implementation framework for clinical adoption.
- Open Access
- 15 November 2025
- Published by SAGE Publications in CARTILAGE
- Vol. 17 (4) , 1268-1284
Knee Bursae: A Comprehensive Review of Clinical Evaluation, Imaging Differentiation, and the Expanding Role of Biologic Therapies
Background: Knee bursae are potential sources of anterior, medial, lateral, and posterior knee pain, yet many remain under-recognized in clinical practice. Emerging biological therapies offer promising, minimally invasive options for resistant bursitis, but high-level evidence is limited for several bursal types. Purpose: To systematically review the anatomy, clinical presentation, imaging characteristics, treatment strategies, and outcomes of 11 distinct knee bursae, with emphasis on the role of biologic therapies. Methods: This systematic review followed PRISMA guidelines. PubMed and Embase were searched (2000-2024) for studies addressing anatomy, diagnosis, imaging, treatment (conservative, injection-based, biologic, or surgical), and outcomes of knee bursae. Studies involving human subjects, published in English, and reporting clinical, imaging, or therapeutic data were included. Levels of Evidence (LOE) were assigned using Oxford criteria. Results: A total of 76 studies were included. Several randomized controlled trials (LOE I) focused on pes anserine and OA-related bursitis, while additional Level II studies assessed PRP and corticosteroids. Data on rare bursae (e.g., LCL, deep infrapatellar) were primarily derived from imaging reviews and case series (LOE III-IV). Corticosteroid injections showed recurrence rates of 20% to 40%. PRP and PRP+HA demonstrated improved pain relief and reduced recurrence in selected bursae, although protocols remain heterogeneous. Conclusion: Conservative management remains first-line for most bursae. PRP-based therapies, especially in pes anserine and OA-related bursitis, offer promising alternatives in refractory cases. Although several Level I-II studies support their efficacy, additional high-quality RCTs are warranted—particularly for understudied bursae.
- 15 November 2025
- Published by SAGE Publications in CARTILAGE
- Vol. 17 (4) , 1268-1284
Open AccessKnee Bursae: A Comprehensive Review of Clinical Evaluation, Imaging Differentiation, and the Expanding Role of Biologic Therapies
Background: Knee bursae are potential sources of anterior, medial, lateral, and posterior knee pain, yet many remain under-recognized in clinical practice. Emerging biological therapies offer promising, minimally invasive options for resistant bursitis, but high-level evidence is limited for several bursal types. Purpose: To systematically review the anatomy, clinical presentation, imaging characteristics, treatment strategies, and outcomes of 11 distinct knee bursae, with emphasis on the role of biologic therapies. Methods: This systematic review followed PRISMA guidelines. PubMed and Embase were searched (2000-2024) for studies addressing anatomy, diagnosis, imaging, treatment (conservative, injection-based, biologic, or surgical), and outcomes of knee bursae. Studies involving human subjects, published in English, and reporting clinical, imaging, or therapeutic data were included. Levels of Evidence (LOE) were assigned using Oxford criteria. Results: A total of 76 studies were included. Several randomized controlled trials (LOE I) focused on pes anserine and OA-related bursitis, while additional Level II studies assessed PRP and corticosteroids. Data on rare bursae (e.g., LCL, deep infrapatellar) were primarily derived from imaging reviews and case series (LOE III-IV). Corticosteroid injections showed recurrence rates of 20% to 40%. PRP and PRP+HA demonstrated improved pain relief and reduced recurrence in selected bursae, although protocols remain heterogeneous. Conclusion: Conservative management remains first-line for most bursae. PRP-based therapies, especially in pes anserine and OA-related bursitis, offer promising alternatives in refractory cases. Although several Level I-II studies support their efficacy, additional high-quality RCTs are warranted—particularly for understudied bursae.